197 related articles for article (PubMed ID: 28143927)
1. Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
Okamoto H; Cavino K; Na E; Krumm E; Kim S; Stevis PE; Harp J; Murphy AJ; Yancopoulos GD; Gromada J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2747-2752. PubMed ID: 28143927
[TBL] [Abstract][Full Text] [Related]
2. Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.
Galsgaard KD; Winther-Sørensen M; Ørskov C; Kissow H; Poulsen SS; Vilstrup H; Prehn C; Adamski J; Jepsen SL; Hartmann B; Hunt J; Charron MJ; Pedersen J; Wewer Albrechtsen NJ; Holst JJ
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E93-E103. PubMed ID: 28978545
[TBL] [Abstract][Full Text] [Related]
3. Angptl4 links α-cell proliferation following glucagon receptor inhibition with adipose tissue triglyceride metabolism.
Ben-Zvi D; Barrandon O; Hadley S; Blum B; Peterson QP; Melton DA
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15498-503. PubMed ID: 26621734
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
Kim J; Okamoto H; Huang Z; Anguiano G; Chen S; Liu Q; Cavino K; Xin Y; Na E; Hamid R; Lee J; Zambrowicz B; Unger R; Murphy AJ; Xu Y; Yancopoulos GD; Li WH; Gromada J
Cell Metab; 2017 Jun; 25(6):1348-1361.e8. PubMed ID: 28591637
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-like protein 4 is an exercise-induced hepatokine in humans, regulated by glucagon and cAMP.
Ingerslev B; Hansen JS; Hoffmann C; Clemmesen JO; Secher NH; Scheler M; Hrabĕ de Angelis M; Häring HU; Pedersen BK; Weigert C; Plomgaard P
Mol Metab; 2017 Oct; 6(10):1286-1295. PubMed ID: 29031727
[TBL] [Abstract][Full Text] [Related]
6. Increased SLC38A4 Amino Acid Transporter Expression in Human Pancreatic α-Cells After Glucagon Receptor Inhibition.
Kim J; Dominguez Gutierrez G; Xin Y; Cavino K; Sung B; Sipos B; Kloeppel G; Gromada J; Okamoto H
Endocrinology; 2019 May; 160(5):979-988. PubMed ID: 30938753
[TBL] [Abstract][Full Text] [Related]
7. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
[TBL] [Abstract][Full Text] [Related]
8. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
Okamoto H; Cavino K; Na E; Krumm E; Kim SY; Cheng X; Murphy AJ; Yancopoulos GD; Gromada J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2753-2758. PubMed ID: 28115707
[TBL] [Abstract][Full Text] [Related]
9. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
[TBL] [Abstract][Full Text] [Related]
10. Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.
Liu Q; Lin G; Chen Y; Feng W; Xu Y; Lyu J; Yang D; Wang MW
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002801
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL4 promotes bile acid absorption during taurocholic acid supplementation via a mechanism dependent on the gut microbiota.
Janssen AWF; Dijk W; Boekhorst J; Kuipers F; Groen AK; Lukovac S; Hooiveld GJEJ; Kersten S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1056-1067. PubMed ID: 28733267
[TBL] [Abstract][Full Text] [Related]
12. Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease.
Sipos B; Klöppel G
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37260318
[TBL] [Abstract][Full Text] [Related]
13. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
Zhou C; Dhall D; Nissen NN; Chen CR; Yu R
Pancreas; 2009 Nov; 38(8):941-6. PubMed ID: 19657311
[TBL] [Abstract][Full Text] [Related]
14. Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish.
Li M; Dean ED; Zhao L; Nicholson WE; Powers AC; Chen W
J Endocrinol; 2015 Nov; 227(2):93-103. PubMed ID: 26446275
[TBL] [Abstract][Full Text] [Related]
15. A Primary Role for α-Cells as Amino Acid Sensors.
Dean ED
Diabetes; 2020 Apr; 69(4):542-549. PubMed ID: 31653720
[TBL] [Abstract][Full Text] [Related]
16. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P
Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640
[TBL] [Abstract][Full Text] [Related]
17. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
Gelling RW; Du XQ; Dichmann DS; Romer J; Huang H; Cui L; Obici S; Tang B; Holst JJ; Fledelius C; Johansen PB; Rossetti L; Jelicks LA; Serup P; Nishimura E; Charron MJ
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1438-43. PubMed ID: 12552113
[TBL] [Abstract][Full Text] [Related]
18. Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.
Holst JJ; Wewer Albrechtsen NJ; Pedersen J; Knop FK
Diabetes; 2017 Feb; 66(2):235-240. PubMed ID: 28108603
[TBL] [Abstract][Full Text] [Related]
19. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
Mattijssen F; Kersten S
Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
[TBL] [Abstract][Full Text] [Related]
20. Crispr-Cas9 mediated complete deletion of glucagon receptor in mice display hyperglucagonemia and α-cell hyperplasia.
Yuan H; Kang Q; Li Z; Bai X; Jia J; Han D; Wu X; Li M
Biochem Biophys Res Commun; 2023 Feb; 643():121-128. PubMed ID: 36596263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
